Illumina, a biotechnology company headquartered in California, will pay $9.8 million settlement to resolve allegations that it violated the False Claims Act. The case claims that Illumina knowingly sold genomic sequencing systems with significant cybersecurity vulnerabilities to federal agencies. Illumina’s Former Employee Blows the Whistle The allegations against Illumina were first brought to light in […] The post Illumina Settles False Claims Act Cybersecurity Case for $9.8 Million app...
